What is it about?
Feline injection site sarcoma (FISS) is a common tumor among cats, for which existing medical treatments do not prove be entirely satisfactory. In this case report, we describe the use of masitinib, a tyrosine kinase inhibitor, in the treatment and the prevention of FISS.
Featured Image
Why is it important?
This therapeutic case report is the first description of the use of masitinib, a tyrosine kinase inhibitor, in the treatment and the prevention of feline injection site sarcoma.
Read the Original
This page is a summary of: Medical approach to the treatment of feline injection site sarcoma with masitinib: a case report, Veterinary Medicine Research and Reports, September 2014, Dove Medical Press,
DOI: 10.2147/vmrr.s67118.
You can read the full text:
Contributors
The following have contributed to this page
